Home > Resources > Infographics > Pharmacies Vs. Dispensaries: the Future of MMJ

Pharmacies Vs. Dispensaries: the Future of MMJ

May 22, 2019

As an influx of cannabis customers turn to the plant for medicinal purposes, it creates a disruptive trend for the traditional OTC and pharmaceutical drug markets. Here, BDS Analytics shares a sampling of key cannabis insights in an infographic created exclusively for mg (it appeared in the April, 2019 issue), including spending forecasts for both synthetic and naturally derived cannabis-based pharmaceuticals, the state of clinical trials for cannabis-derived drugs, prescription medication usage trends, and more.

Spotlight

Outpatient Imaging Affiliates

OIA partners with healthcare providers such as health systems, academic medical centers, and radiology groups to develop, market and operate quality, patient friendly, service oriented outpatient imaging centers. OIA’s business model is to invest equity in each project alongside its local partners while providing development, management, marketing, billing and collection services to the joint venture.

Other Infographics

What Does The Pharma IndustryWant From CROs?

Infographic | June 16, 2022

Use Informa Pharma Intelligence’s marketing and pharma expertise to conduct industry research, produce engaging thought leadership content,

Smart Pharmacovigilance

Infographic | May 23, 2021

Pharmacovigilance (PV) is essential to all life science organizations, ensuring that patients' health comes first. Various trends in global healthcare have transformed today’s PV function into a corporate asset that enhances brand value and contributes to new growth opportunities. However, existing safety systems impose a significant cost burden to operate.

2021 global life sciences outlook

Infographic | August 24, 2021

The life sciences sector has played a pivotal role amid the COVID-19 pandemic. To cope with the global crisis, traditional competitors partnered to accelerate research and develop the fastest novel vaccine in the history. Governments, health systems, payers, retail pharmacies, and nonprofits are now working collaboratively with the sector to provide widespread distribution and administration.

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Taking Pharmacy Benefits on a New Ride

Infographic | December 1, 2019

Rideshare companies like Uber and Lyft challenged the old way of doing things with a new approach. It’s not just about getting from point A to point B anymore, it’s about the experience, convenience and added value. The same applies to pass-through PBMs (pharmacy benefit managers) that are challenging the status quo to make prescriptions more affordable..

Pharmacies Vs. Dispensaries: the Future of MMJ